
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
Este novedoso corazón artificial sin válvulas se implantó —por primera vez en seres humanos— en un paciente con insuficiencia cardíaca...
Houston, TX (July 10, 2024) – The Texas Heart Institute is proud to announce the inaugural Cardiometabolic Syndrome Conference taking...
On June 14, The Texas Heart Institute’s School of Perfusion Technology congratulated the eight June 2024 graduates of its long-standing...
On June 7, The Texas Heart Institute honored 11 graduates of its Cardiovascular Disease Fellowship and subspecialty cardiology fellowship programs....
The International Society for Heart and Lung Transplantation (ISHLT) has named The Texas Heart Institute President and CEO Joseph G....
The ASAIO Board of Trustees has named Dr. O.H. Frazier, recipient of the prestigious Pushpa and Kewal Krishan Gupta Lifetime...
This week, the American Heart Association held its annual Epidemiology and Prevention Lifestyle and Cardiometabolic Scientific Sessions 2024 in Chicago. A preliminary...
Georgia Tech-led effort to improve support device options for end-stage heart failure HOUSTON (Mar 7, 2024) — The Texas...
On Saturday, March 2, 2024, The Texas Heart Institute hosted THI Rodeo Roundtable 2024: Cardiogenic Shock, a discussion group chaired...
Top to Toe Transcatheter Solutions Conference 2024 (4TS 2024) was a momentous event that marked a decade of groundbreaking achievements...
HOUSTON (January 30, 2024) — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The...